소세포

Small-cell lung cancer (SCLC)   – 13–15% of newly diagnosed lung cancer per year.  – Most patients present with extensive stage disease     –> expected survival : 2~4 months without Tx. Five year survival rates   – Limited-stage SCLC : 10–13%  – Extensive-stage SCLC : 1–2% WHO classification – 2 types of SCLC : pure … 더 읽기